stockrowNordicus Partners Corporation (NORD) vs Spero Therapeutics, Inc. (SPRO)
- Nordicus Partners Corporation NORD 3.52 +9.32%
- Spero Therapeutics, Inc. SPRO 1.08 +4.85%
Nordicus Partners Corporation and Spero Therapeutics, Inc. are both Biotechnology companies. Nordicus Partners Corporation and Spero Therapeutics, Inc. are of similar size ($68.4M and $62.3M). Nordicus Partners Corporation has negative trailing earnings, so its P/E is not meaningful; Spero Therapeutics, Inc. trades at 7.7×. Spero Therapeutics, Inc. grew revenue faster over the last twelve months: 37.2% against −71.7%. Across the 14 metrics below, Spero Therapeutics, Inc. leads on 13 and Nordicus Partners Corporation on 1.
Valuation
Profitability
| Metric | NORD | SPRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 70.18% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (8.06%) | 19.17% | (50.82%) |
| Return on assets | (6.80%) | 12.85% | (46.04%) |
| Return on invested capital | (4.43%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack